clinton, his one-time fierce rival, should succeed him. the white house has released excerpts of the speech, which reads in part, "there has never been a man or a woman more qualified than hillary clinton to serve as president of the united states of america." also scheduled to speak tonight, vice president biden and mrs. clinton's running mate, virginia senator tim kaine. the daughter of president ronald reagan has criticized a judge's decision to grant freedom to john hinckley junior, the man who shot the president and three others in washington 35 years ago. on her website, patty davis says that her heart is sickened by the decision. once hinckley is released from a government psychiatric hospital, he will live with his mother in williamsburg, virginia. the turkish state run news agency says close to 7000 officers have been formerly discharged -- formally discharged from the military after the country's failed coup. the government has decided to

close dozens of media organizations, including 45 newspapers and 16 television stations. global news 24 hours a day, powered by more than 2600 journalists and analysts in more than 120 countries. i am mark crumpton. this is bloomberg. "bloomberg west" is next. ♪ ♪ emily: i am emily chang, and this is "bloomberg west." facebook blows past second quarter earnings estimates thanks to a surge in mobile ads. i spoke to sheryl sandberg about how they keep it up. plus, t-mobile ends a winning streak in monthly subscribers but beats on the rest. cfo.uld hear from their and the explosion in health

tech. facebook shares soaring after hours, up as much as 8% as facebook beat on sales, profit, monthly, and datily active users, getting a big lift from what mark zuckerberg has called "the golden age of online video." i spoke to sheryl sandberg about video driving engagement on the social network. the explosion of video on the platform is great for consumers and great for our business. if you think about all the new formats, and a lot of them are video, like life, but also -- live, but also recorded video and 360 pictures. these are contribute into our time spent metric. emily: the time spent on the platform is paying off. facebook now has more than 1.7 billion monthly users, and two thirds of them use facebook every single day. here with me to break down the earnings, the ceo of cargo, and an analyst with forrester, from

cambridge. is it as good as it sounds? harry: facebook has done an incredible job getting the entire world on its platform. advertisers are following where the people are. so when you look at the actual ads on facebook, you see they are less brand advertising and more app install ads, but in terms of reaching users all over the world, facebook has done an incredible job given people on the platform. adsy: you think the app are a weakness? i call it the cocaine of the advertising world. if you are a startup and you are venture funded and you need people to get on your platform, facebook is one of the best ways to get those people to actually install those apps on their phones. emily: that's what we see a lot onads for lyft and instacart facebook. the ventures that

have gone out, creating uber for food, uber for laundry, ways to get average goods delivered to your home, there needs to be a way to get those services out, and facebook has been a catalyst for installs of those apps. there's a question whether brand advertisers will migrate to facebook, versus traditional places where they advertise, on great editorial properties that have a voice, like bloomberg. emily: that said, they added $2 billion to revenue year-over-year. is there a problem here? >> you know, it's going to be very difficult for facebook to continue with the, the explosive growth that they have had. thus far, given the fact that they are continuously able to mau numbers,au and that signals they have a skill in keeping and attracting users, which is significant. the fact that their ad revenue continues to grow at this time

is also significant, and speaks to investments they have made in mobile, video, and measurement. another interesting note is the activity that brands are creating around messenger, so the fact that brands are moving to create chatbot experiences, that speaks to them seeing that platform as a potential extension of their brand. emily: when it comes to messenger and whatsapp, i asked sheryl sandberg about monetization opportunities there, and she gave hints those are coming. take a look at what she had to say. sheryl: we are not breaking out instagram, but facebook is still the main driver of revenue growth but instagram is making a real contribution. we are excited about what is happening with instagram. we announced, 200,000 active advertisers, 75% outside the u.s. between facebook and instagram, we have the two most important mobile ad platforms.

that's why we are seeing strong growth. emily: that is instagram. now let's hear what she had to say about messenger and whatsapp. we are in messenger, looking at organic activity happening between businesses and llyertisers, and we are rea happy to see we have one billion messages sent per month between businesses and people, almost all organic activity. we are doing very early testing to see how we can monetize and drive those engagements between businesses and consumers, but right now it is organic activity that we are looking for. emily: you are worried about the overreliance on app install ads, but these platforms have not even turned on the firehose yet. doesn't -- does messenger and potential?ld huge harry: they spent about 30 million dollars on whatsapp.

it's a lot. when you look at asia and wechat and the platforms now supporting commerce, line in japan and wechat in china, more and more commerce is taking place on messaging platforms. the degree that those same function start to spread in the united states, where people use chat and messenger to do transactions, if they can be in the platform and bring advertising into the platform, that will be a really interesting new growth area for them. it will be a totally different game, probably a totally different set of advertisers in there, but certainly because they own those platforms, and messenger seems to be the next growth area in terms of how people communicate, it's exciting. emily: what about instagram, erna? instagramt estimated probably brought in $550 million this quarter, which could rise

to $2.5 billion for the year. does facebook really have the two most powerful mobile ad platforms in the world? erna: it's pretty hard not to think that, given again the user growth, as well is the advertising revenue as a whole that the facebook ecosystem is pushing. instagram has definitely showed its value in terms of attracting a different type of audience with visual mediums. with continued investments in the platform, i completely expect to see increased revenue ahead, as well as increased users. emily: how worried are you about snapchat and competitors? think snapchat will step in and take some of that instagram money. no question, for young users, between the ages of i would say eight and 20, we see almost all of their activity at least on a daily basis, you see it shifting, and i see it in my own family.

my 13 year old is assessed with snapchat -- obsessed with snapchat. the majority of their money comes up from people wanting to set up filters, but brands can realize that filters are a great way to integrate messaging into where consumers are posting, and that will create a shift in budgets away from instagram and into snapchat, because there's only so much money to go around. emily: analysts we have spoken to say they have not seen a noticeable impact from snapchat on facebook. do you think this will happen at some point? erna: there will be some movement, if only to -- it's only to be expected, given that consumers use these networks for different purposes. given the particular audience, slight shift in terms of dollars going to snapchat because of the need to speak to a younger audience. that being said, either way it will still drive significant

value, at least for the next year. emily: the last thing, was around facebook live. there is so much momentum behind facebook live right now, and they believe that is driving time spent on facebook. one thing they said, they are not interested in long form content deals, like twitter signing up the nfl games -- the nfl games. how important do you think facebook live will be to the platform overall? anry: facebook live is just indication of them wanting to go head-to-head with youtube.there's so many dollars shifting away from tv, which continues to decline, that when you look at where the tv dollars will migrate to, they will migrate to digital. what platforms will capture them? today, youtube is the key platform that captures the vast majority of those video dollars, and tomorrow what facebook is saying, they want to be involved

in capturing more of the video dollars shifting from tv. emily: erna, what is your take on facebook live? how powerful is it? one thing sheryl said, they will not be adding ads around facebook live, but if it does well, that enables them to make more money on ads via facebook live. erna: i think facebook live is just part of the overall roadmap to making sure the majority of content on facebook in the next five years happens to be video. way of yet anotherr attracting a different have of content producer, as well as another impetus for users to get in on the video game. it will be interesting to see how the battle plays out between twitter and facebook. they both have different approaches, but they also both have different goals, so there is more to this story.

emily: we will be covering. erna, harry, thank you both so much for joining us. shares of groupon are soaring after hours. the company posted a second-quarter loss but boosted its full-year sales outlook to $3.1 billion. ceo rich williams is trying to ane the company to being online destination for people looking for bargains. gopro declined 47% in the second quarter, but still better than analysts expected. they said they will return to profitability in the fourth quarter. the company is also expected to release a new model of camera later this year. still to come, tesla unveils its biggest bet yet. a sneak peek at the gigafactory in the nevada desert. this is bloomberg. ♪

emily: one stock we continue to watch, nintendo. shares down another 5% after a series of disappointing updates from the game maker. last week, nintendo said it would not be able to rely on the success of pokemon go to boost profits. the company set a highly anticipated accessory for the game is delayed until september. the net loss for this quarter was also wider than analysts projected. t-mobile says it is holding on to the users it lured from rivals through discounts, reporting fewer subscriber defections than any time in history. but it also fell short of one million postpaid scriber's for the first time in two years.

i spoke to cfo braxton carter and asked him what happened. braxton: everything is working well, and momentum continues. what you see on a macro basis in the wireless industry is lower overall switching among carriers. at&t, verizon, and t-mobile all reported lower churn, and that's really important, because there's not as many people out making the decision. what drives that is iconic handset launches, and we have a significant one coming up with the apple iphone. emily: does a recovering sprint threaten t-mobile's underdog favorite status that you have been riding on the last couple years? braxton: you know, it's really a myth. sprint doing well or doing poorly has nothing to do with the momentum of t-mobile. based,our growth is first of all, on the fastest 4g

lte network in the country. we put over $20 billion over the last four years. if you have not tried us lately, you have not tried us. we have one incredibly network that is highly differentiated against all the other carriers. that's the foundation. but the vast majority of our consumers are primarily coming from at&t and verizon, and sprin t, just due to the relative size in the marketplace, really do esn't make much of a difference to us either way. emily: interesting. verizon, which is the market leader, made a big deal this, week buying yahoo! for $4.8 billion. the goal is to build out mobile video and advertising. are they getting ahead of the curve, or taking their eye off the ball? braxton: you know, they certainly have a strategy that they are aggressively pursuing. congratulations to them. on another acquisition.

this now totals $10 billion of acquisitions in this space. we are totally focused on wireless. we are completely focused on providing mobility as the internet goes completely mobile. did you see the amazing phenomenon with pokemon go?> that's just a taste of what is to come, and that's why our focus on mobility and being the fastest-growing company in america in wireless is so important. emily: braxton carter, t-mobile's cfo. its debut ining the laptop market, releasing specs of a new device that sure bears a striking was a lens to another up -- resemblance to another laptop. the mi notebook air will be on sale in china in august. no word on if they will be available anywhere else. coming up, apple might be during

up to join the ridesharing wars. the details next. this is bloomberg.

emily: tesla has given us a look at its biggest bet yet. the electric carmaker gave a media tour of the $5 billion gigafactory under construction in sparks, nevada. construction began two years ago, and it is 14% complete. they are building the factory to cut the cost of making tesla batteries by a third. it is also a key part of elon musk's goal to make half a million cars by 2018. musk has sped up production schedules to meet that goal. tim cook may have dropped the biggest hint yet about apple's car aspirations, explaining the rationale behind $1 billion of investment in a chinese company during this call. a greatsee that as

financial investment, and we think there's some strategic things the companies can do together over time, and we think we will learn a lot about that market, and the chinese even beyond what we currently know. didi has an incredible team there. that's the rationale for why we did that. emily: joining us now to discuss what this may mean for the ridesharing landscape, gabe klein from washington, d.c. everybody wants to read between the lines. does this mean you may be able to summon an apple software and car at some point in the future? gabe: someday, probably so. you are seeing the convergence of technology and business models and the way they interface with people's lives. whether you are talking about autouto men -- big

manufacturers or startups, everybody is jumping in this game, because they realize how big it is. emily: what do you think about the apple car's future in particular? we heard that they hired bob mansfield, former engineering head, to run this project. what are you reading into this? gabe: i think cars are complex. and whether it is google or apple, they realized getting into the car business might be harder than they thought, and partnerships will ultimately be very important. apple has done an amazing job of keeping this project titan completely under the radar. job have done an amazing keeping people buttoned up on it. but the fact is, they are building a vehicle. they see it as an extension of their services, competing with google. with google feeding a lot of the china market, apple sees this as a big potential in and win for them. apple's investment in

didi, it gives a for middle competitor to uber, and elon musk has a plan to take on uber as well with self driving tesla s. who stands a better chance, uber or tesla? gabe: in this world we live in, we are used to a winner takes all situation, whether it's amazon or uber or facebook with social media, and with transportation i think it will be different. i don't see a winner takes all world out there. if you look at the airline industry, it's heavily regulated it'susly, or it was, but not like there is one option to fly. we have autonomous shared-use airplanes for 30 years, and we will see the same thing with transportation. we will have a lot of entrants into this market, and bigger

ones than smaller ones.cultural differences are important . also, we are urbanizing at a rapid pace, and for the first time in history have more people living in cities than not living in cities worldwide, and people are giving up owned automobiles, not making that capital expenditure. 88% of people moving to d.c., wh ether they are here for the long-term or the short-term, they are not bringing or buying an automobile, not making that investment. instead, they are using these services, so there is room for a lot of competition. emily: last quick question. in europe, another uber competitor teamed up with daimler's ridesharing service. in china you have didi and lyft teaming up. in europe, how well-positioned is uber vis-a-vis the competition? gabe: not positioned terribly well. they made some big mistakes when they entered into europe a couple years ago.

the governments of various countries were not happy with their behavior, so they have left the door open for people like daimler and halo. they are doing much better in asia. i was in singapore and shanghai recently, and you can get an uber within minutes. lyft got a risible partnership with grab taxi. there are a lot of interesting partnerships going on, but europe is going to be one where i think the taxis have more of a hold on the market than in asia or the u.s. thanks soe klein, much for joining us. up next, our weekly roundtable on vc trends. this week, talking health tech. this is bloomberg. ♪

mark: i am mark crumpton. this is your first word news. donald trump says he has never met russian president vladimir putin, and is not convinced russia was responsible for the

democratic national committee e-mail hacking. but in an unusual appeal from a major party's presidential nominee, trump today called for russia to hack hillary clinton's e-mail. >> russia, if you are listening, i hope you are able to find the 30,000 e-mails that are missing. i think you will probably be rewarded mightily by our press. mark: the clinton campaign called trump's statement "the first time that a major presidential candidate has actively encouraged a foreign power to conduct espionage against a political opponent." the democratic national committee was warned last fall that its computer network was susceptible to attacks, but it did not follow the security advice it was given. that's according to people familiar with the matter. the fast and recent public disclosure of thousands of e-mails led to the resignation of dnc chairwoman debbie wasserman schultz. pope francis says the world is at war, but he is stressing it

is not a war of religions. he is in poland, where he urged the country's leaders to "overcome fear and show compassion to migrants." i am mark crumpton. this is bloomberg. it is just after 6:30 p.m. in new york, a: 30 in's -- 8:30 in sydney. paul has a look at the markets. good morning. paul: good morning, mark. trade in new zealand has been up and running for 30 minutes now, and it's pretty quiet at the moment, the index off just a few points. we are expecting modest gains here on the asx at the open. the picture looks mixed in japan. it will be interesting to see the market reaction to the stimulus speech delivered by japanese prime minister shinzo abe on wednesday night. billion.ion, $285 that number was really buried in the speech. we will wait for details on whether that is new money. seems to be to the

benefit for the bank of japan. we will keep an eye on nissan, the automaker announcing an 11% drop in profit, to $1.3 billion. strong impact from the yen, which appreciated 18% against the u.s. dollar during that quarter. nissan maintaining its financial billion.of 500 and ¥5 waiting on samsung earnings for the second quarter, coming out within the hour. i am paul allen for bloomberg tv in sydney, australia. ♪ this is "bloomberg west." it is time for serious a -- series a, our weekly roundtable

on vc. this week, health tech. exploring the issues on the cutting edge of health care disruption. i sat down with two people who have been investing in this for years. and robertn middendorf. i started by asking them why health tech has suddenly grabbed the attention of traditional vc's. esther: the affordable basically says that you will get paid to keep people healthy. it's not totally happening yet. it's amazing how slow the medical system is to respond to incentives, just the way people are slow to take care of thieeir own health, but it's begin to happen, and health systems are beginning to realize how we can make money by preventing diabetes as well as by treating it. estherrobert: we have seen threr

shifts. the market for digitized health information started with the high-tech act, with the government funding $30 billion to digitize health care information. then, the affordable care act changed how doctors and health systems are paid. they are becoming more paid on a warranty-like care model versus doing procedures. adopt, seen the consumer as well as physicians and health care dividers, digital technologies. you have the infrastructure in place, the data in place, and the payment in place to create a new laboratory for change. emily: esther, you are focused on seed stage, and robert, you do series a. you are an investor in 23andme a nd other companies. what is your personal philosophy for guiding the decisions you make? esther: because it is my own

money, i can really take risks. i can do things i like. i don't have a list of criteria. i haveme, fundamentally, become much more interested in actual to bidding health, than in paying later to recapture health. you can make money in both of them, but philosophically i would much rather prevent diabetes than treat people with it. somehat i'm looking for, of this has changed because i'm doing a nonprofit and i don't want a conflict of interest, but to me, the ultimate business model for a huge mound of this is an app with the curriculum, ser feedback data, plus coaching. because that innovation part is so hard. coaches, mental health services. it's all a combination of something digital, some kind of data tracking, and human beings

that keep you motivated. emily: you are wearing your wearables. robert, you invest in wearables and other digital health companies. what is your philosophy? esther: i agree with a lot of that -- robert: i agree with a lot of that. one of the big things we have looked at in health care, captured by talkspace. taking the labor of health care, whether it is a physician or a therapist or a nurse, and helping to improve their ability to scale to more patients over time. if you look at the labor in health care over the next 20 to 30 years, we are going to fall short in the u.s. to deliver care face to face, one-on-one, and there's a couple ways around that. you can either go to lower cost, less well-trained providers, which we will do, and you can take the current providers we have and will have and use software to help automate the more routine aspects of their work. you will see that. took a program being used

face to face were a counselor might train 16 to 30 people, and they are scaling it to a situation where a counselor can manage 1000 patients over time. emily: companies like google, alphabet, through some of their other ventures, they are investing heavily in life sciences and health tech. what makes it different from your traditional consumer tech investing? esther: can i just make one other point? you are right, you take less well-trained people, but to me that's actually a huge benefit. i'm working with small committees, trying to help them become healthy. one way you become healthy is by using these devices and having these coaches. another way you become healthy is by getting trained to do a job that has meaning. one of the bigger problems that will happen over time will be, more stuff gets automated, but there's a huge number of potential jobs for people without a lot of college degrees. upy patients and up -- end

becoming counselors themselves, so if a third of the community is employed keeping the other two thirds healthy, that's actually a pretty good deal. emily: now, you have a portfolio across a lot of different sectors. what makes health tech different from traditional consumer tech? robert: there's probably two things. it goes back to a regulation and payments. we were investors in basis and misfit, consumer wearable companies selling to consumers. you tend to have not as much regulation, and you tend to get paid by the person using the product. in health care, the person who is paying for the product is currently still someone different than the person who gets the product. so i would say that we tend to take a very pragmatic approach. we definitely see a massive amount of innovation happening, and we want to be given not to disrupt the system

too much. we like to look for investments that have enough sensibility that they play by the existing rules. emily: that is esther dyson and robert middendorf. we will pick up where we left off and explore the fine line between health care disruption and federal regulation, and of course the cautionary tale of theranos. thios is bloomberg. ♪

emily: this is "bloomberg west." let's pick back up with our weekly vc roundtable, focus on health tech investing with robert binn north and esther dyson. esther is on the board of 23andme. i asked her what she learned from the company's regulatory struggles in recent years.

esther: i invested in 23andme and joined the board because i thought i would learn a ton, and i did. it was very important that they do not have fraud or honesty issues. we failed to provide the data the government asked for, and we got slapped pre-doing that. then we provided the data. we are still providing a lot of data. now actually- are working very closely with the fda, and they kind of like us, as an example of how you can work closely and effectively. the truth is, i like having the fda there, because it keeps the riff-raff out, and there is a lot of snake oil, people who promise amazing things. i have no idea what evidence they are based on. yes, we had our problems, but in the end, we are talking about

people's health. it'sare not likely to -- still done by doctors. there's an awful lot of stuff that i'm glad is not being marketed. emily: you mentioned fraud, honesty issues, promising snake oil. these are things that have come up, especially with regard to theranos. os is guilty thera of these things? esther: i don't know enough to comment. robert: i would say in general, the complexity of bringing a new innovation to market in health care requires a lot of knowledge. the only thing i would say there, i think it is useful to look at who was involved in a company, and what experience they had in bringing new complex services and technologies to the market. i would echo one thing. i am an emergency physician. when i'm not wearing my investor hat, i'm thinking similar to the -- similarly to the fda about patient safety.

on the investor and, you have to think about pushing the boundaries, but we have to rememeber, giving the wrong data can result in life-changing decisions that may not be so good. so the answer is, companies that have worked effectively with the fda, and medicare in the case of betters, probably have a chance of innovating than those that do not. emily: is there a risk we might see more theranoses? esther: in any field, there are people who take advantage. the issue is, we both believe in empowering individuals and not even treating them like patients always. consumers, people monitoring their own health. but at the same time, there are lots of people out there who are not that educated and are looking for a quick fix, and they are vulnerable. so the same way we regulate

pensions and financial instruments, stuff like that, because people will always try to take advantage, and, you know, it's good to have a few morality tales that encourage people to innovate carefully when you are talking about people's health. emily: what is the right burden of evidence, when it comes to regulation? what should these companies have to prove? thatr: they need to prove their thing does good, at least for some people, and that it doesn't harm anybody. emily: what about that it works? esther: but the interesting thing, with precision medicine, is that there are many drugs, and also many approaches to motivating people. most drugs are not 100% effective. they are 100% effective with 40% of the people, and maybe helpful

to 10%. but you want to make sure that for the rest, they are useless rather than harmful. emily: go ahead. robert: i think it's a balance between what you said, the effect, and the risk to the patient, or the cost on the other side. whether you are looking at a drug or a digital intervention, the first question is, how much money can you save the system, and how much for the patient or the provider for the payer, and what can you have clinically, at what risk? the fda has done a pretty good job with their mobile health guidance that they started releasing in 2013 to balance, to say, if you have a chronic condition, we are not changing drug dosing. that is a mobile medical app that will not require a review. they are balancing risk with return, something the fda has been doing a pretty good job at. but if you're going to try to change the dosing of, say, a chemotherapeutic agent with some

kind of technology, you want to make sure you have more clinical evidence before you distribute that. emily: esther dyson, robert middendorf. aboutl be talking more series asruption when continues after the break. ♪

emily: this is "bloomberg west." now back to our weekly vc roundtable, this week focused on investing in health tech. i sat down with as the dyson of edventure holdings and robert mittendorf, and asked if the

disruptive thinking of silicon valley applies. esther: it is more new markets. right now, they are probably too many obesity and diabetes prevention programs. and an investor in omada, i'm interested in watching blue mesa health, solara health, a others -- bunch of others. because it is such a huge problem, it is going to be huge. sleep monitoring is going to get better, and people are going to realize how important it is. everybody is going to get not just a pulse monitor, but, if you have any indications of owner ability, some -- vulnerability, some kind of real-time ekg that is a lot more sensitive than just your pulse. you will be able to detect stuff. more interestingly you are going to be able to change it,, because you will be using feedback.

now, there is still human nature.we love sugar and so forth. but i'm hoping, we may need some government interference as well as collective action to combat that. robert: i would say probably the biggest, if we look at investors -- investments we made, is that you are taking tasks in health care delivered by providers and trying to figure out how to do those with software. and when you start trying to do that, you start using machine learning and artificial intelligence, so i would think, the next 10 years, some of the biggest wins will be taking evidence-based and rules-based methods of medicine being deployed by providers and even insurance companies today, and putting them in machine learning and ai, pieces of software that will first enable providers to see more patients and do more things more quickly. think about like turbotax, versus doing your own taxes manually. there is still a human involved in data entry and making

decisions. ultimately, who knows when this will happen, some of those tasks will be fully automated by ai, some of the lower-level tasks. emily: i wanted to take a few moments to do a lightning round. i will mention a few different technologies, and i would like to know if you think, within 10 years, will this be ubiquitous, or mainstream? first of all, you are wearing your, what are you wearing on your wrist? emily: a fuelband, which is unfortunately out of production. i do love it. and i have a jawbone, the battery is dead. and an oura ring from finland, that is the best consumer sleep monitor out there. mine. i am not wearing will everybody be wearing health tracking devices in 10 years? emily: everybody sort of of the top 60% or 70%, in some form,

but they will have to become much better, more seamless, and the most exciting thing is, we will have real-time glucose monitors for anybody who needs them. emily: robert, you invested in misfit. robert: i wear them during workouts. running with elevation and stuff. i would say, we will all be wearing or carrying sensors that we do not carry today or did not carry 10 years ago. most phones are now capturing your activity, so i think, if you think broadly in terms of that, i think the vast majority of people will be sensorized. emily: what about chips in our bodies? emily: not in 10 years -- esther: not in 10 years, but very easy. robert: for certain people, but not most of us. emily: in our clothing? robert: in some form. emily: genetic sequencing for all? i'm looking at you. esther: yes. it's like giving her blood type. emily: will that happen when we are born? esther: or before you were born.

and more interestingly, you talked about sequencing tumors or whatever weird things happen. robert: definitely a significant percentage of the population will get sequenced, whether it -- the to get technical entire genome is another question, but costs are driving the two almost an inevitability. emily: how about a replacement for antibiotics? i don't know if we are getting to scientific here. robert: no. emily: why not? robert: in the next 10 years? there's other approaches to treating infectious disease, but the bigger concern for infectious disease is resistance that will require new agents. so i think you will see more drugs, because the bacteria are winning in some areas, but i don't think we will be able to get rid of and about x. -- get rid of antibiotics. esther: we will do lots of other things, including sterilizing infectious agents, like

mosquitoes. -- replacing and about antibiotics, some of them will no longer be useful is the bigger problem. emily: instant medical test results? esther: already exist. robert: continued. convenience, especially in the u.s. as consumers start to bear more of the burden with high deductible plans, convenience, pricing, and the ability to see the data yourself will become more important. key technology exists. emily: what about instant blood test results? everyone wonders, is it really possible? esther: it is. not just here, but in the developing world, that's going to be key. emily: that was esther dyson of edventure holdings and robert mittendorf, norwwest venture -- norwest venture partners. you can find our in-depth discussions on all the serious a interviews at bloomberg.com. that does it for this edition of

"bloomberg west." tomorrow, more coverage of big tech earnings after the bell. amazon, alphabet, and more. that is all for today from san francisco. ♪

♪ >> from our studios in new york city, this is "charlie rose." welcome to the program, day two of the democratic national convention in philadelphia. over my shoulder, you can see the podium where hillary clinton will accept the nomination and make her speech on thursday night. earlier this evening, her husband spoke about her. president clinton: one day, i was driving her to the airport when we passed this little break house that had a for sale sign on it. she said, boy, that's a pretty house. it had 1100 square